Diagnostic Approach to Microcytic Anemia with High RDW

Diagnostic Significance of Laboratory Pattern

The American College of Physicians recommends that an RDW >14-16.9% strongly distinguishes iron deficiency from thalassemia trait, which typically presents with normal or only slightly elevated RDW 1, 3
High RDW reflects heterogeneous red cell populations as iron stores become progressively depleted, often appearing before MCV changes become apparent, as noted by the American Medical Association 3, 2
This pattern creates a distinctive signature that differentiates iron deficiency from anemia of chronic disease and thalassemia, according to the American College of Physicians 1, 3

The American College of Physicians recommends that serum ferritin is the single most powerful test and must be obtained immediately to confirm iron deficiency, with a ferritin <30 μg/L confirming iron deficiency in the absence of inflammation 1, 2
Ferritin <100 μg/L may still indicate iron deficiency if inflammation is present, as noted by the American Medical Association 1, 2
The American College of Physicians recommends measuring transferrin saturation and CRP simultaneously with ferritin to assess for functional iron deficiency and interpret ferritin correctly in the context of inflammation 1, 2

The American Gastroenterological Association recommends that all adult men and post-menopausal women with confirmed iron deficiency require complete gastrointestinal evaluation, regardless of symptom presence, including upper endoscopy with mandatory small bowel biopsies and colonoscopy or CT colonography 2
This presentation warrants investigation for malignancy, as gastrointestinal blood loss is the most common source in these populations, according to the American Cancer Society 2

The American College of Physicians recommends that if ferritin confirms iron deficiency (<30 μg/L), oral iron supplementation should be initiated, and continued for 3-6 months after hemoglobin normalizes to replete iron stores 2
The American Medical Association notes that treatment of the underlying cause will cure the anemia, making identification of the source critical, and recommends addressing any identified GI pathology and investigating for occult gastrointestinal blood loss, menstruation, pregnancy, or malabsorption 2, 3

The American Society of Hematology recommends considering X-linked sideroblastic anemia (XLSA) due to ALAS2 defects in patients with pyridoxine-responsive or unresponsive mild microcytic sideroblastic anemia, and initial treatment with pharmacologic doses of pyridoxine (50-200 mg per day) 4
The American Society of Hematology notes that SLC25A38 defects in children with severe unexplained microcytic sideroblastic anemia require hematopoietic stem cell transplantation as the only curative option 4